Description of current practices of empiric chemotherapy dose adjustment in obese adult patients (Q33846184)

29 July 2017

Description of current practices of empiric chemotherapy dose adjustment in obese adult patients (English)

1 reference

29 July 2017

0 references

1 reference

Lisa A Thompson

1

1 reference

29 July 2017

Amber P Lawson

2

1 reference

29 July 2017

Stephanie D Sutphin

3

1 reference

29 July 2017

Douglas Steinke

4

1 reference

29 July 2017

Val R Adams

5

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Journal of Oncology Practice

29 July 2017

1 reference

29 July 2017

6

1 reference

29 July 2017

3

1 reference

29 July 2017

141-145

1 reference

Chemotherapy dosing strategies in the obese, elderly, and thin patient: results of a nationwide survey

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Breast cancer adjuvant chemotherapy dosing in obese patients: dissemination of information from clinical trials to clinical practice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Prevalence of overweight and obesity in the United States, 1999-2004

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Impact of obesity in the setting of high-dose chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Effects of obesity on pharmacokinetics implications for drug therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Estimation of creatinine clearance when urine cannot be collected.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Prediction of creatinine clearance from serum creatinine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868639

Pharmacokinetic considerations in obesity

29 October 2018

1 reference

12 December 2020

Obesity is not associated with increased myelosuppression in patients receiving chemotherapy for breast cancer

1 reference

12 December 2020

Amikacin pharmacokinetics in morbidly obese patients undergoing gastric-bypass surgery

1 reference

12 December 2020

1 reference

12 December 2020

Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass

1 reference

12 December 2020

Amikacin pharmacokinetics in morbidly obese patients

1 reference

12 December 2020

Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer

1 reference

12 December 2020

Identifiers

DOI

10.1200/JOP.200016

1 reference

29 July 2017

1 reference

29 July 2017

1 reference